Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000929638-25-003884·Biomea Fusion, Inc.
Schedule 13D ownership disclosure
BIOMEA FUSION INC
Common Stock · CUSIP: 09077A106
Event date: 2025-10-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cormorant Global Healthcare Master Fund, LPReported CIK 0001618442
Shares: 1,795,928 · Class: 2.59%
- Cormorant Global Healthcare GP, LLCReported CIK 0001618451
Shares: 1,795,928 · Class: 2.59%
- Cormorant Private Healthcare Fund III LPReported CIK 0001817320
Shares: 1,717,232 · Class: 2.48%
- Cormorant Private Healthcare GP III, LLC
Shares: 1,717,232 · Class: 2.48%
- Cormorant Asset Management, LPReported CIK 0001583977
Shares: 3,570,872 · Class: 5.15%
- Chen BihuaReported CIK 0001599214
Shares: 3,681,664 · Class: 5.31%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-25-003884
- Form type
- SCHEDULE 13D/A
- Filer
- Biomea Fusion, Inc.
- CIK
- CIK 1840439
- Filed
- Oct 10, 2025
- Reporting period
- Oct 08, 2025
- Description
- Schedule 13D beneficial ownership